Adult stem cells and multiple sclerosis

Cell Proliferation

Volumn 44, Issue SUPPL. 1, 2011, Pages 35-38

  Scolding, N ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ALZHEIMER DISEASE; ARTICLE; BONE MARROW CELL; DISABILITY; EMBRYONIC STEM CELL; HUMAN; INFLAMMATION; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE CELL LESION; NERVE CONDUCTION; NERVE FIBER; NEUROLOGIC DISEASE; OLIGODENDROGLIA; STEM CELL TRANSPLANTATION;

ADULT; ADULT STEM CELLS; BONE MARROW TRANSPLANTATION; HUMANS; MULTIPLE SCLEROSIS;

EID: 79953862301     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00721.x     Document Type: Article

References (42)

1. Blakemore WF (1977) Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature 266, 68-69.
2. Scolding NJ (1997) Strategies for repair and remyelination in demyelinating diseases. Curr. Opin. Neurol. 10, 193-200.
3. Perier O, Gregoire A (1965) Electron microscopic features of multiple sclerosis lesions. Brain 88, 937-952.
4. Albert M, Antel J, Bruck W, Stadelmann C (2007) Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 17, 129-138.
5. Patani R, Balaratnam M, Vora A, Reynolds R (2007) Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 33, 277-287.
6. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20, 6404-6412.
7. Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P (2001) Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann. Neurol. 49, 776-785.
8. Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J (1998) Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121, 2221-2228.
9. Wilson HC, Scolding NJ, Raine CS (2006) Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J. Neuroimmunol. 176, 162-173.
10. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18, 601-609.
11. Snethen H, Love S, Scolding N (2008) Disease-responsive neural precursor cells are present in multiple sclerosis lesions. Regen. Med. 3, 835-847.
12. Chard D, Miller D (2009) Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective. Curr. Opin. Neurol 22, 214-218.
13. Evangelou N, DeLuca GC, Owens T, Esiri MM (2005) Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 128, 29-34.
14. Filippi M, Rocca MA (2005) MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J. Neurol. 252(Suppl. 5), v16-v24.
15. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128, 2705-2712.
16. Korbling M, Estrov Z (2003) Adult stem cells for tissue repair. N. Engl. J. Med. 349, 570-582.
17. Rice CM, Scolding NJ (2004) Adult stem cells - reprogramming neurological repair? Lancet 364, 193-199.
18. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E et al. (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61, 219-227.
19. Gordon D, Pavlovska G, Glover CP, Uney JB, Wraith D, Scolding NJ (2008) Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection and with sparse CNS infiltration. Neurosci. Lett. 448, 71-73.
20. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E et al. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755-1761.
21. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB et al. (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol. 195, 16-26.
22. Akiyama Y, Radtke C, Honmou O, Kocsis JD (2002) Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39, 229-236.
23. Akiyama Y, Radtke C, Kocsis JD (2002) Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J. Neurosci. 22, 6623-6630.
24. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. USA 102, 18171-18176.
25. Bai L, Caplan A, Lennon D, Miller RH (2007) Human mesenchymal stem cells signals regulate neural stem cell fate. Neurochem. Res. 32, 353-362.
26. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD et al. (2009) Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57, 1192-1203.
27. Rivera FJ, Couillard-Despres S, Pedre X, Ploetz S, Caioni M, Lois C et al. (2006) Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 24, 2209-2219.
28. Rice CM, Scolding N (2010) Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination. Cell Adh. Migr. 4(2), 235-40.
29. Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M et al. (2005) Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49, 407-417.
30. Chen Q, Long Y, Yuan X, Zou L, Sun J, Chen S et al. (2005) Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J. Neurosci. Res. 80, 611-619.
31. Garcia R, Aguiar J, Alberti E, de la Cuetara K, Pavon N (2004) Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem. Biophys. Res. Commun. 316, 753-754.
32. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX et al. (2002) Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514-523.
33. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N (2009) Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. 3, 63-70.
34. Ye M, Chen S, Wang X, Qi C, Lu G, Liang L et al. (2005) Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat. NeuroReport 16, 581-584.
35. Kemp K, Hares K, Mallam E, Heesom KJ, Scolding N, Wilkins A (2009) Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. J. Neurochem. 114, 1569-1580.
36. Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel SY et al. (2008) Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat. Cell Biol. 10, 575-583.
37. Nygren JM, Liuba K, Breitbach M, Stott S, Thoren L, Roell W et al. (2008) Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat. Cell Biol. 10, 584-592.
38. Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA et al. (2004) Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 363, 1432-1437.
39. Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B (2003) Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. USA 100, 1364-1369.
40. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R et al. (2008) Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299, 925-936.
41. Rice CM, Scolding NJ (2008) Autologous bone marrow stem cells - properties and advantages. J. Neurol. Sci. 15, 59-62.
42. Rice CM, Mallam EA, Whone AL, Walsh P, Brooks DJ, Kane N et al. (2010) Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. Clin. Pharmacol. Ther. 87, 679-685.